[Advances in the Treatment of Multiple Primary Lung Cancer].

Q4 Medicine

中国肺癌杂志 Pub Date : 2025-06-20 DOI:10.3779/j.issn.1009-3419.2025.102.17

Ying Xiao, Xiaobo Chen, Xinghe Tong, Xudong Yang, Yanlong Yang, Yunping Zhao

引用次数: 0

Abstract

In recent years, the incidence of multiple primary lung cancer (MPLC) has been increasing, and it cannot be ignored in clinical practice. The treatment of MPLC is still controversial, but surgical treatment is recognized as the most important treatment. However, current studies have shown that the treatment of MPLC needs to develop multimodal treatment according to different patients. This review summarizes multiple treatment method for MPLC, including surgery, ablation, chemotherapy, radiotherapy, targeted therapy, and immunotherapy in order to enhance understanding of MPLC treatment. .

查看原文本刊更多论文

【多发性原发性肺癌的治疗进展】。

近年来，多发性原发肺癌（multiple primary lung cancer， MPLC）的发病率不断上升，在临床实践中不容忽视。MPLC的治疗仍有争议，但手术治疗被认为是最重要的治疗方法。然而，目前的研究表明，MPLC的治疗需要根据不同的患者发展多模式治疗。本文综述了MPLC的多种治疗方法，包括手术、消融、化疗、放疗、靶向治疗和免疫治疗，以提高对MPLC治疗的认识。 。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中国肺癌杂志 Medicine-Pulmonary and Respiratory Medicine

CiteScore

1.40

自引率

0.00%

发文量

5131

审稿时长

14 weeks

期刊介绍： Chinese Journal of Lung Cancer(CJLC, pISSN 1009-3419, eISSN 1999-6187), a monthly Open Access journal, is hosted by Chinese Anti-Cancer Association, Chinese Antituberculosis Association, Tianjin Medical University General Hospital. CJLC was indexed in DOAJ, EMBASE/SCOPUS, Chemical Abstract(CA), CSA-Biological Science, HINARI, EBSCO-CINAHL,CABI Abstract, Global Health, CNKI, etc. Editor-in-Chief: Professor Qinghua ZHOU.